The departure and replacement of the Principal Accounting Officer is a standard succession event with no expected disruption to financial reporting or operations. Monitor for any subsequent changes in the finance team, but no immediate trading action is warranted.
Price Chart
Executive Summary
Rocket Pharmaceuticals disclosed the resignation of VP of Finance and Principal Accounting Officer John Militello, effective July 7, 2026, to pursue other opportunities. Joseph Manhede, the company's Associate VP of Corporate Controller since April 2026, was appointed as the new Principal Accounting Officer effective July 8, 2026. This is a routine internal succession with no material financial or operational impact.
Key Facts
- John Militello resigned as VP of Finance, Senior Controller, Treasurer and Principal Accounting Officer, effective July 7, 2026.
- Joseph Manhede appointed as Principal Accounting Officer effective July 8, 2026.
- Manhede has served as Associate VP, Corporate Controller since April 2026 and has prior experience at Outlook Therapeutics, Amneal Pharmaceuticals, and Deloitte.
- No new compensatory arrangements were entered into with Manhede in connection with the appointment.
Financial Impact
No financial impact; routine officer change with no compensation changes.
Market Snapshot
Investment Themes
Documents Analyzed
This report is based on 4 SEC documents filed with EDGAR.
| Document | Accession Number |
|---|---|
| 8-K Filing (Primary) | 0001140361-26-026982 |
| Document: 0001140361-26-026982-index-headers.html | 0001140361-26-026982 |
| Document: 0001140361-26-026982-index.html | 0001140361-26-026982 |
| Document: 0001140361-26-026982.txt | 0001140361-26-026982 |
Filters
| Type | Now | ||||
|---|---|---|---|---|---|
Sep 15, 2026 17d ago | 8-K | $3.41 $3.35 | ▼ −1.76% | ▼ −3.89% | $2.56 (−24.93%) |
Aug 20, 2026 6w ago | Insider Cluster | $3.48 $3.62 | ▲ +4.02% | ▲ +2.91% | $2.56 (−26.44%) |
Aug 17, 2026 6w ago | Insider Cluster | $3.34 $3.78 | ▲ +13.17% | ▲ +13.37% | $2.56 (−23.35%) |
Aug 13, 2026 7w ago | Insider Cluster | $3.34 $3.48 | ▲ +4.04% | ▲ +6.01% | $2.56 (−23.35%) |
Aug 10, 2026 7w ago | 8-K | $3.50 $3.34 | ▼ −4.57% | ▼ −4.17% | $2.56 (−26.86%) |
Aug 3, 2026 8w ago | 8-K | $3.41 $3.64 | ▲ +6.74% | ▲ +4.72% | $2.56 (−24.93%) |
Jun 30, 2026 13w ago | 8-K | $3.52 $4.07 | ▲ +15.63% | ▲ +15.36% | $2.56 (−27.27%) |
Jun 12, 2026 16w ago | 8-K | $2.75 $3.35 | ▲ +21.82% | ▲ +21.15% | $2.56 (−6.91%) |
May 26, 2026 18w ago | Insider Cluster | $2.99 $2.92 | ▼ −2.34% | ▼ −2.81% | $2.56 (−14.38%) |
May 7, 2026 21w ago | Insider Cluster | $3.25 $2.96 | ▼ −8.92% | ▼ −9.89% | $2.56 (−21.23%) |
US Market Status
Subscribe to SecBot
Get Real-Time SEC Filing Intelligence
Comprehensive SEC filing analysis delivered the moment filings hit EDGAR. Sentiment scoring, impact analysis, and actionable insights for every material event.
Try SecBot Free Coming soon: SecBot Pro with alerts, watchlists, and API access